🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Response and Content Removal

Based on the social media company, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with numerous of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially serious health risks”.